Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–BioNTech) COVID‐19 vaccine

Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–BioNTech) COVID‐19 vaccine

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatologic therapy 2022-11, Vol.35 (11), p.n/a
Hauptverfasser: Hlaca, Nika, Zagar, Tina, Kastelan, Marija, Peternel, Sandra, Brajac, Ines, Dujmovic‐Hasanbegovic, Katarina, Prpic‐Massari, Larisa
Format: Artikel
Sprache:eng
Schlagworte:
Letter
Letters
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 11
container_start_page
container_title Dermatologic therapy
container_volume 35
creator Hlaca, Nika
Zagar, Tina
Kastelan, Marija
Peternel, Sandra
Brajac, Ines
Dujmovic‐Hasanbegovic, Katarina
Prpic‐Massari, Larisa
description
doi_str_mv 10.1111/dth.15791
format Article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9538535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DTH15791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3921-6612e7a0f32924e423bcabbce35f3672f5843ad97fd97de9e51a6c8c988e7503</originalsourceid><addsrcrecordid>eNp1UMtOAjEUbYxGEF34B13KYqAPOjPdmCCokBAghri06XRaqBkoaXkEV3yCiX_IlziKMXHhTW7uufeecxYHgGuMGrisZr6aNTBLOD4BVcwIj1KE-WmJKY8jRHhcARchvCKECaf4HFRoXF4RTargZWxXO29lsAH6deYlXNpC-nIzrijc1i6mMHMurLSHuQsaOgPnT8M2vBkb-6b9Yf9xZ91wotWsDjuj5373sH_HHG6kUnahL8GZkUXQVz-zBiYP95NOLxqMHvud9iBSlBMcxTEmOpHIUMJJS7cIzZTMMqUpMzROiGFpi8qcJ6bsXHPNsIxVqnia6oQhWgO3R9vlOpvrXOnFystCLL2dS78TTlrx97OwMzF1G8EZTRllpUH9aKC8C8Fr86vFSHxlLMqMxXfGJbd55G5toXf_E0V30jsqPgGIWX8c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–BioNTech) COVID‐19 vaccine</title><source>Access via Wiley Online Library</source><creator>Hlaca, Nika ; Zagar, Tina ; Kastelan, Marija ; Peternel, Sandra ; Brajac, Ines ; Dujmovic‐Hasanbegovic, Katarina ; Prpic‐Massari, Larisa</creator><creatorcontrib>Hlaca, Nika ; Zagar, Tina ; Kastelan, Marija ; Peternel, Sandra ; Brajac, Ines ; Dujmovic‐Hasanbegovic, Katarina ; Prpic‐Massari, Larisa</creatorcontrib><identifier>ISSN: 1396-0296</identifier><identifier>EISSN: 1529-8019</identifier><identifier>DOI: 10.1111/dth.15791</identifier><identifier>PMID: 36029037</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Letter ; Letters</subject><ispartof>Dermatologic therapy, 2022-11, Vol.35 (11), p.n/a</ispartof><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3921-6612e7a0f32924e423bcabbce35f3672f5843ad97fd97de9e51a6c8c988e7503</citedby><cites>FETCH-LOGICAL-c3921-6612e7a0f32924e423bcabbce35f3672f5843ad97fd97de9e51a6c8c988e7503</cites><orcidid>0000-0002-8318-8031 ; 0000-0003-1491-7998 ; 0000-0002-0517-5462 ; 0000-0001-8590-0451 ; 0000-0003-3572-6197 ; 0000-0002-0308-4057</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdth.15791$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdth.15791$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Hlaca, Nika</creatorcontrib><creatorcontrib>Zagar, Tina</creatorcontrib><creatorcontrib>Kastelan, Marija</creatorcontrib><creatorcontrib>Peternel, Sandra</creatorcontrib><creatorcontrib>Brajac, Ines</creatorcontrib><creatorcontrib>Dujmovic‐Hasanbegovic, Katarina</creatorcontrib><creatorcontrib>Prpic‐Massari, Larisa</creatorcontrib><title>Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–BioNTech) COVID‐19 vaccine</title><title>Dermatologic therapy</title><subject>Letter</subject><subject>Letters</subject><issn>1396-0296</issn><issn>1529-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1UMtOAjEUbYxGEF34B13KYqAPOjPdmCCokBAghri06XRaqBkoaXkEV3yCiX_IlziKMXHhTW7uufeecxYHgGuMGrisZr6aNTBLOD4BVcwIj1KE-WmJKY8jRHhcARchvCKECaf4HFRoXF4RTargZWxXO29lsAH6deYlXNpC-nIzrijc1i6mMHMurLSHuQsaOgPnT8M2vBkb-6b9Yf9xZ91wotWsDjuj5373sH_HHG6kUnahL8GZkUXQVz-zBiYP95NOLxqMHvud9iBSlBMcxTEmOpHIUMJJS7cIzZTMMqUpMzROiGFpi8qcJ6bsXHPNsIxVqnia6oQhWgO3R9vlOpvrXOnFystCLL2dS78TTlrx97OwMzF1G8EZTRllpUH9aKC8C8Fr86vFSHxlLMqMxXfGJbd55G5toXf_E0V30jsqPgGIWX8c</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Hlaca, Nika</creator><creator>Zagar, Tina</creator><creator>Kastelan, Marija</creator><creator>Peternel, Sandra</creator><creator>Brajac, Ines</creator><creator>Dujmovic‐Hasanbegovic, Katarina</creator><creator>Prpic‐Massari, Larisa</creator><general>John Wiley &amp; Sons, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8318-8031</orcidid><orcidid>https://orcid.org/0000-0003-1491-7998</orcidid><orcidid>https://orcid.org/0000-0002-0517-5462</orcidid><orcidid>https://orcid.org/0000-0001-8590-0451</orcidid><orcidid>https://orcid.org/0000-0003-3572-6197</orcidid><orcidid>https://orcid.org/0000-0002-0308-4057</orcidid></search><sort><creationdate>202211</creationdate><title>Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–BioNTech) COVID‐19 vaccine</title><author>Hlaca, Nika ; Zagar, Tina ; Kastelan, Marija ; Peternel, Sandra ; Brajac, Ines ; Dujmovic‐Hasanbegovic, Katarina ; Prpic‐Massari, Larisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3921-6612e7a0f32924e423bcabbce35f3672f5843ad97fd97de9e51a6c8c988e7503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Letter</topic><topic>Letters</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hlaca, Nika</creatorcontrib><creatorcontrib>Zagar, Tina</creatorcontrib><creatorcontrib>Kastelan, Marija</creatorcontrib><creatorcontrib>Peternel, Sandra</creatorcontrib><creatorcontrib>Brajac, Ines</creatorcontrib><creatorcontrib>Dujmovic‐Hasanbegovic, Katarina</creatorcontrib><creatorcontrib>Prpic‐Massari, Larisa</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Dermatologic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hlaca, Nika</au><au>Zagar, Tina</au><au>Kastelan, Marija</au><au>Peternel, Sandra</au><au>Brajac, Ines</au><au>Dujmovic‐Hasanbegovic, Katarina</au><au>Prpic‐Massari, Larisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–BioNTech) COVID‐19 vaccine</atitle><jtitle>Dermatologic therapy</jtitle><date>2022-11</date><risdate>2022</risdate><volume>35</volume><issue>11</issue><epage>n/a</epage><issn>1396-0296</issn><eissn>1529-8019</eissn><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>36029037</pmid><doi>10.1111/dth.15791</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-8318-8031</orcidid><orcidid>https://orcid.org/0000-0003-1491-7998</orcidid><orcidid>https://orcid.org/0000-0002-0517-5462</orcidid><orcidid>https://orcid.org/0000-0001-8590-0451</orcidid><orcidid>https://orcid.org/0000-0003-3572-6197</orcidid><orcidid>https://orcid.org/0000-0002-0308-4057</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1396-0296
ispartof Dermatologic therapy, 2022-11, Vol.35 (11), p.n/a
issn 1396-0296
1529-8019
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9538535
source Access via Wiley Online Library
subjects Letter
Letters
title Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–BioNTech) COVID‐19 vaccine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T19%3A03%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pityriasis%20rubra%20pilaris%20following%20booster%20dose%20of%20mRNA%20(Pfizer%E2%80%93BioNTech)%20COVID%E2%80%9019%20vaccine&rft.jtitle=Dermatologic%20therapy&rft.au=Hlaca,%20Nika&rft.date=2022-11&rft.volume=35&rft.issue=11&rft.epage=n/a&rft.issn=1396-0296&rft.eissn=1529-8019&rft_id=info:doi/10.1111/dth.15791&rft_dat=%3Cwiley_pubme%3EDTH15791%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/36029037&rfr_iscdi=true